XENETIC BIOSCIENCES, INC. Other Non-Current Liabilities
XENETIC BIOSCIENCES, INC. (XBIO) had Other Non-Current Liabilities of $6.18 thousand as of 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2019-08-14
- 2019-06-30: Other Liabilities, Noncurrent $6.18K.
- 2019-03-31: Other Liabilities, Noncurrent $13.12K.
- 2018-12-31: Other Liabilities, Noncurrent $0.00.
- 2017-12-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2019-06-30 | $6.18K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $13.12K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $0.00 10-Q · filed 2019-08-14 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-30 |
| 2017-09-30 | $4.98K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $10.02K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $15.02K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $19.88K 10-K · filed 2018-03-30 |
| 2016-09-30 | $24.73K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $29.45K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $34.13K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $38.79K 10-K · filed 2017-03-31 |
| 2015-09-30 | $43.27K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $47.65K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $52.15K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $56.38K 10-K · filed 2016-03-30 |
| 2014-09-30 | $60.73K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $64.88K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $70.61K 10-Q · filed 2014-05-20 |
| 2013-12-31 | $0.00 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |